Eurepa Mf 1mg Tablet belongs to the therapeutic classification of Antidiabetic Agents The primary composition for this medicine is Metformin 500 MG Repaglinide 1 MG

Some diabetic patients taking Eurepa MF 1 Tablet 10 s may develop a rare but serious condition called lactic acidosis In this condition there is too much lactic acid accumulated in the blood So your liver and kidney s proper functioning is required to eliminate excess lactic acid from the blood You should not take Eurepa MF 1 Tablet 10 s if you have kidney disease as measured by a blood test Eurepa MF 1 Tablet 10 s may lower vitamin B12 levels so try to have blood test annual blood and vitamin Eurepa MF 1 Tablet 10 s when used with or without insulin tends to lower the blood sugar level extremely So the doctor may lower the dose of insulin Eurepa MF 1 Tablet 10 s may lower your thyroid stimulating hormone TSH so an annual check up of TSH is suggested